13F filer · CIK 315066 ↗
Fidelity Investments
You are looking at Q1 2023. See the latest, Q2 2026 →
Reported value
$2.19T
+117% on the quarter before
Positions
5,256
398 new · 479 sold out
Top 10
26.2%
of the value
Est. gain
+$88.91B
on stocks held all quarter
Est. return
+9.0%
on those stocks since Q4 2022
Positions as of Mar 31, 2023, from Fidelity Investments's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 36% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2022. Striped tiles are options.
Largest buys
Since Q4 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Microsoft~$58.25BAdded · 4.7% → 5.3%+202,061,085 shares
- Apple~$49.75BAdded · 4.1% → 4.7%+301,712,741 shares
- Nvidia~$37.62BAdded · 2.0% → 3.5%+135,447,070 shares
- Amazon~$26.50BAdded · 2.5% → 2.6%+256,599,378 shares
- Meta~$25.80BAdded · 1.5% → 2.4%+121,724,927 shares
- Unitedhealth Group Inc~$20.14BAdded · 2.5% → 2.0%+42,612,440 shares
- Alphabet~$20.02BAdded · 2.0% → 2.0%+192,974,263 shares
- Exxon Mobil Corp~$16.19BAdded · 1.6% → 1.5%+147,630,184 shares
- Berkshire Hathaway Inc Del~$14.91BAdded · 1.5% → 1.4%+32,015 shares
- Visa Inc.~$10.78BAdded · 1.0% → 1.0%+47,813,779 shares
Largest sells
Since Q4 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Linde Plc~$4.17BSold out · 0.4% → 0.0%−12,762,981 shares
- Oak Str Health Inc~$934.1MCut · 0.1% → 0.0%−24,148,083 shares
- Intercontinental Exchange In~$439.3MCut · 0.1% → 0.0%−4,212,413 shares
- Idexx Labs Inc~$316.4MCut · 0.1% → 0.0%−632,610 shares
- Eqt Corp~$309.9MCut · 0.1% → 0.0%−9,712,166 shares
- Synchrony Financial~$302.5MCut · 0.1% → 0.0%−10,403,431 shares
- Signature Bk New York N Y~$297.1MSold out · 0.0% → 0.0%−2,578,770 shares
- Ambev Sa~$289.5MCut · 0.0% → 0.0%−102,655,922 shares
- Coupa Software Inc~$211.0MSold out · 0.0% → 0.0%−2,665,539 shares
- Peabody Energy Corp~$202.9MCut · 0.0% → 0.0%−7,925,408 shares
Holdings
As of Mar 31, 2023. Changes are in shares against Dec 31, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +102% · price +20.2% | 5.3% | $115.62B | +$9.65B | ||||||||
| AppleCOM · shares +94% · price +26.9% | 4.7% | $102.71B | +$11.23B | ||||||||
| NvidiaCOM · shares +99% · price +90.1% | 3.5% | $75.79B | +$18.08B | ||||||||
| AmazonCOM · shares +86% · price +23.0% | 2.6% | $57.30B | +$5.75B | ||||||||
| MetaCL A · shares +99% · price +76.1% | 2.4% | $51.76B | +$11.22B | ||||||||
| AlphabetCAP STK CL A · shares +87% · price +17.6% | 2.0% | $43.12B | +$3.45B | ||||||||
| Unitedhealth Group IncCOM · shares +88% · price −10.9% | 2.0% | $43.02B | −$2.79B | ||||||||
| Exxon Mobil CorpCOM · shares +104% · price −0.6% | 1.5% | $31.79B | −$91.1M | ||||||||
| Berkshire Hathaway Inc DelCL A · shares +100% · price −0.7% | 1.4% | $29.77B | −$99.3M | ||||||||
| Eli LillyCOM · shares +90% · price −6.1% | 1.0% | $21.98B | −$756.2M | ||||||||
| AlphabetCAP STK CL C · shares +73% · price +17.2% | 1.0% | $21.96B | +$1.87B | ||||||||
| Visa Inc.COM CL A · shares +99% · price +8.5% | 0.99% | $21.72B | +$859.1M | ||||||||
| MastercardCL A · shares +94% · price +4.5% | 0.78% | $16.97B | +$377.6M | ||||||||
| NetflixCOM · shares +101% · price +17.2% | 0.74% | $16.28B | +$1.19B | ||||||||
| Regeneron PharmaceuticalsCOM · shares +70% · price +13.9% | 0.71% | $15.51B | +$1.11B | ||||||||
| SalesforceCOM · shares +104% · price +50.7% | 0.66% | $14.53B | +$2.40B | ||||||||
| Wells Fargo Co NewCOM · shares +112% · price −9.5% | 0.65% | $14.28B | −$703.4M | ||||||||
| TeslaCOM · shares +108% · price +68.4% | 0.63% | $13.83B | +$2.70B | ||||||||
| Bank America CorpCOM · shares +93% · price −13.6% | 0.62% | $13.48B | −$1.10B | ||||||||
| Lululemon Athletica IncCOM · shares +100% · price +13.7% | 0.61% | $13.37B | +$804.3M | ||||||||
| Thermo Fisher Scientific IncCOM · shares +103% · price +4.7% | 0.60% | $13.09B | +$286.6M | ||||||||
| General Electric CoCOM NEW · shares +111% · price +14.1% | 0.56% | $12.20B | +$712.5M | ||||||||
| Boston Scientific CorpCOM · shares +125% · price +8.1% | 0.52% | $11.38B | +$380.4M | ||||||||
| Marvell Technology IncCOM · shares +101% · price +16.9% | 0.51% | $11.13B | +$801.1M | ||||||||
| Jpmorgan Chase & CoCOM · shares +89% · price −2.8% | 0.50% | $11.01B | −$169.8M | ||||||||
| Total · 5,256 positions | 100% | $2.19T | +$88.91B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2022 to Q1 2023: 4,662 stocks held throughout, up $88.91B (+9.0%).
- Nvidia+$18.08B+90%
- Apple+$11.23B+27%
- Meta+$11.22B+76%
- Microsoft+$9.65B+20%
- Amazon+$5.75B+23%
- Eli Lilly−$756.2M−6%
- Bank America Corp−$1.10B−14%
- Monster Beverage Corp New−$1.17B−47%
- The Cigna Group−$1.23B−23%
- Unitedhealth Group Inc−$2.79B−11%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 56 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $2.30T+21% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.90T−3% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $1.96T+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $1.92T+8% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $1.77T+13% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.57T−7% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $1.68T+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $1.64T+5% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $1.56T+5% | SEC ↗ |
| Q1 2024 | May 13, 2024 | $1.49T+14% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $1.30T+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $1.16T−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $1.19T−45% | SEC ↗ |
| Q1 2023 | May 11, 2023 (amended) | $2.19T+117% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $1.01T+5% | SEC ↗ |
| Q3 2022 | Nov 10, 2022 | $958.93B−4% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $1.00T−20% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $1.25T−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $1.35T+7% | SEC ↗ |
| Q3 2021 | Feb 14, 2022 (amended) | $1.26T−1% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $1.28T+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $1.17T+4% | SEC ↗ |
| Q4 2020 | Feb 8, 2021 | $1.12T+14% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $989.33B+9% | SEC ↗ |
| Q2 2020 | Aug 24, 2020 (amended) | $909.48B+26% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $722.13B−20% | SEC ↗ |
| Q4 2019 | Feb 7, 2020 | $906.40B+9% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $833.77B−3% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $856.19B+3% | SEC ↗ |
| Q1 2019 | May 13, 2019 (amended) | $834.93B+14% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 (amended) | $730.25B−18% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $888.88B+2% | SEC ↗ |
| Q2 2018 | Aug 10, 2018 (amended) | $868.68B+3% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $842.35B−1% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $853.06B+3% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $827.12B+3% | SEC ↗ |
| Q2 2017 | Aug 29, 2017 (amended) | $804.55B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $787.10B+5% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 (amended) | $748.25B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $750.86B+2% | SEC ↗ |
| Q2 2016 | Aug 11, 2016 | $732.58B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $722.80B | SEC ↗ |